Current Strategies for the Manufacture of Small Size Tissue Engineering Vascular Grafts

Abstract

Occlusive arterial disease, including coronary heart disease (CHD) and peripheral arterial disease (PAD), is the main cause of death, with an annual mortality incidence predicted to rise to 23.3 million worldwide by 2030. Current revascularization techniques consist of angioplasty, placement of a stent, or surgical bypass grafting. Autologous vessels, such… (More)
DOI: 10.3389/fbioe.2018.00041

3 Figures and Tables

Topics

  • Presentations referencing similar topics